2jnd › Citations

Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand.

Grace CR, Perrin MH, Gulyas J, Digruccio MR, Cantle JP, Rivier JE, Vale WW, Riek R
Proc Natl Acad Sci U S A 104 4858-63 (2007)
Cited: 80 times
EuropePMC logo PMID: 17360332

Abstract

The corticotropin releasing factor (CRF) family of ligands and their receptors coordinate endocrine, behavioral, autonomic, and metabolic responses to stress and play additional roles within the cardiovascular, gastrointestinal, and other systems. The actions of CRF and the related urocortins are mediated by activation of two receptors, CRF-R1 and CRF-R2, belonging to the B1 family of G protein-coupled receptors. The short-consensus-repeat fold (SCR) within the first extracellular domain (ECD1) of the CRF receptor(s) comprises the major ligand binding site and serves to dock a peptide ligand via its C-terminal segment, thus positioning the N-terminal segment to interact with the receptor's juxtamembrane domains to activate the receptor. Here we present the 3D NMR structure of ECD1 of CRF-R2beta in complex with astressin, a peptide antagonist. In the structure of the complex the C-terminal segment of astressin forms an amphipathic helix, whose entire hydrophobic face interacts with the short-consensus-repeat motif, covering a large intermolecular interface. In addition, the complex is characterized by intermolecular hydrogen bonds and a salt bridge. These interactions are quantitatively weighted by an analysis of the effects on the full-length receptor affinities using an Ala scan of CRF. These structural studies identify the major determinants for CRF ligand specificity and selectivity and support a two-step model for receptor activation. Furthermore, because of a proposed conservation of the fold for both the ECD1s and ligands, this structure can serve as a model for ligand recognition for the entire B1 receptor family.

Reviews - 2jnd mentioned but not cited (3)

  1. Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. Park PS, Lodowski DT, Palczewski K. Annu Rev Pharmacol Toxicol 48 107-141 (2008)
  2. Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors. Pal K, Melcher K, Xu HE. Acta Pharmacol Sin 33 300-311 (2012)
  3. Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors. Culhane KJ, Liu Y, Cai Y, Yan EC. Front Pharmacol 6 264 (2015)

Articles - 2jnd mentioned but not cited (6)



Reviews citing this publication (22)

  1. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Kenakin T, Miller LJ. Pharmacol Rev 62 265-304 (2010)
  2. Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Parthier C, Reedtz-Runge S, Rudolph R, Stubbs MT. Trends Biochem Sci 34 303-310 (2009)
  3. Insights into the structure of class B GPCRs. Hollenstein K, de Graaf C, Bortolato A, Wang MW, Marshall FH, Stevens RC. Trends Pharmacol Sci 35 12-22 (2014)
  4. The Corticotropin-Releasing Factor Family: Physiology of the Stress Response. Deussing JM, Chen A. Physiol Rev 98 2225-2286 (2018)
  5. Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles. Hay DL, Pioszak AA. Annu Rev Pharmacol Toxicol 56 469-487 (2016)
  6. Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Grammatopoulos DK. Br J Pharmacol 166 85-97 (2012)
  7. International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors. Gardella TJ, Vilardaga JP. Pharmacol Rev 67 310-337 (2015)
  8. Consequences of splice variation on Secretin family G protein-coupled receptor function. Furness SG, Wootten D, Christopoulos A, Sexton PM. Br J Pharmacol 166 98-109 (2012)
  9. Drugability of extracellular targets: discovery of small molecule drugs targeting allosteric, functional, and subunit-selective sites on GPCRs and ion channels. Grigoriadis DE, Hoare SR, Lechner SM, Slee DH, Williams JA. Neuropsychopharmacology 34 106-125 (2009)
  10. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs. Lee SM, Booe JM, Pioszak AA. Eur J Pharmacol 763 196-205 (2015)
  11. Endocrinology and the brain: corticotropin-releasing hormone signaling. Inda C, Armando NG, Dos Santos Claro PA, Silberstein S. Endocr Connect 6 R99-R120 (2017)
  12. Current understanding of the structure and function of family B GPCRs to design novel drugs. Karageorgos V, Venihaki M, Sakellaris S, Pardalos M, Kontakis G, Matsoukas MT, Gravanis A, Margioris A, Liapakis G. Hormones (Athens) 17 45-59 (2018)
  13. Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders. Vandael D, Gounko NV. Transl Psychiatry 9 272 (2019)
  14. Membrane catalysis of peptide-receptor binding. Langelaan DN, Rainey JK. Biochem Cell Biol 88 203-210 (2010)
  15. Isothermal titration calorimetry in membrane protein research. Draczkowski P, Matosiuk D, Jozwiak K. J Pharm Biomed Anal 87 313-325 (2014)
  16. New insights into the evolution of vertebrate CRH (corticotropin-releasing hormone) and invertebrate DH44 (diuretic hormone 44) receptors in metazoans. Cardoso JC, Félix RC, Bergqvist CA, Larhammar D. Gen Comp Endocrinol 209 162-170 (2014)
  17. Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor. Miller LJ, Dong M, Harikumar KG. Br J Pharmacol 166 18-26 (2012)
  18. Biophysical characterization of G-protein coupled receptor-peptide ligand binding. Langelaan DN, Ngweniform P, Rainey JK. Biochem Cell Biol 89 98-105 (2011)
  19. The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system? Haass-Koffler CL. Alcohol 72 3-8 (2018)
  20. Conformational switches in the VPAC(1) receptor. Langer I. Br J Pharmacol 166 79-84 (2012)
  21. The orthosteric agonist-binding pocket in the prototypic class B G-protein-coupled secretin receptor. Miller LJ, Dong M. Biochem Soc Trans 41 154-158 (2013)
  22. Structural and Functional Insights into CRF Peptides and Their Receptors. Matsoukas MT, Panagiotopoulos V, Karageorgos V, Chrousos GP, Venihaki M, Liapakis G. Biology (Basel) 13 120 (2024)

Articles citing this publication (49)



Quick links